Literature DB >> 34617181

Effect of Cholecystokinin-8 (CCK-8) on Blood Pressure and Blood Content of Calcitonin-Gene-Related Peptide (CGRP) in Rats with Hypertension Caused by Fructose or Inhibition of Nitric Oxide Synthesis.

Z S Tolochko1, V K Spiridonov2.   

Abstract

We studied the effect of CCK-8 on BP and blood content of CGRP in rats with hypertension caused by fructose or inhibition of NO synthase with L-NAME. The decrease in the CGRP content was found during the development of fructose-induced hypertension, but not L-NAME-caused hypertension. Administration of CCK-8 to fructose-fed animals reduced BP and increased the content of CGRP. In rats with hypertension caused by NO deficit, CCK-8 lowered BP, but did not affect the content of CGRP. These findings suggest that CGRP mediates the hypotensive effect of CCK-8 in fructose-induced hypertension, but not in NO-deficient hypertension.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CCK-8; CGRP; L-NAME; fructose; hypertension

Mesh:

Substances:

Year:  2021        PMID: 34617181     DOI: 10.1007/s10517-021-05284-3

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  9 in total

1.  Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit.

Authors:  L Manni; T Lundeberg; P Tirassa; L Aloe
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice.

Authors:  L Manni; L Aloe; P Tirassa; A Finn; T Lundeberg
Journal:  Neuroreport       Date:  2001-06-13       Impact factor: 1.837

Review 3.  Vasodilatory effects of cholecystokinin: new role for an old peptide?

Authors:  Mariano Ruiz-Gayo; M Carmen González; Soledad Fernández-Alfonso
Journal:  Regul Pept       Date:  2006-08-02

4.  Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries.

Authors:  Yoshito Zamami; Shingo Takatori; Narumi Hobara; Nana Yabumae; Panot Tangsucharit; Xin Jin; Naoya Hashikawa; Yoshihisa Kitamura; Kenji Sasaki; Hiromu Kawasaki
Journal:  Hypertens Res       Date:  2011-07-28       Impact factor: 3.872

5.  A novel role for cholecystokinin: regulation of mesenteric vascular resistance.

Authors:  Cristina Sánchez-Fernández; M Carmen González; Philip M Beart; Linda D Mercer; Mariano Ruiz-Gayo; María S Fernández-Alfonso
Journal:  Regul Pept       Date:  2004-09-15

Review 6.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

Review 7.  Pharmacology of CCKRs and SAR studies of peptidic analog ligands.

Authors:  Florence Noble
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 8.  Calcitonin gene-related peptide: physiology and pathophysiology.

Authors:  F A Russell; R King; S-J Smillie; X Kodji; S D Brain
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 9.  Role of sensory nervous system vasoactive peptides in hypertension.

Authors:  R E Watson; S C Supowit; H Zhao; K A Katki; D J Dipette
Journal:  Braz J Med Biol Res       Date:  2002-08-30       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.